During ECR 2023 we sponsored two Symposia with remarkable speakers.
Watch the recording of the Symposia here and let us know your review.

Satellite Symposium (Ultrasound)

Please accept marketing-cookies to watch this video.

Ultrasound Liver Analysis: What’s New - From Early Detection and Diagnosis to Treatment

The prevalence of diffuse liver disease is increasing and is now a worldwide problem. In addition to alcohol abuse or chronic hepatitis, other causes are emerging such as metabolic syndrome leading to a higher prevalence of fatty liver or liver-related diseases. The wide variety of these causes and their impact on the liver require the combination of conventional ultrasound with new advanced diagnostic techniques to provide adequate staging of the patient. This symposium will review the use and diagnostic performance of these techniques such as elastography for the quantification of liver stiffness, fibrosis using Shear wave technology (SWE), the new tissue attenuation parameter (ATI) for the quantification of steatosis or the inflammatory dispersion of liver tissue (SWD).

  • Introduction - Prof. Valérie Vilgrain, Paris, France (moderator)
  • Liver Shear Wave Elastography: SRU Consensus/Attenuation Imaging: Toward Standardization of Measurements - Dr. Giovanna Ferraioli, Pavia, Italy
  • Are We Ready for Global Ultrasound Analysis for Chronic Liver Diseases? - Dr. Marco Dioguardi Burgio, Paris, France
  • Summary and Perspective - Prof. Valérie Vilgrain, Paris, France (moderator)

Satellite Lunch Symposium (CT/MRI)

Please accept marketing-cookies to watch this video.

CT & MRI Screening and Follow-up: What’s New - Clinical Experience with New AI Technologies

The European Union Council recently adopted a new approach to cancer screening, following the Commission's proposal to boost cancer prevention through early diagnosis. This is an important step in improving early detection throughout the EU, which is a fundamental goal of Europe's Beating Cancer Plan. The new strategy calls for gradually expanding population-based screening programs to include lung and prostate. *

This Symposium will concentrate on CT screening for lung cancer and MRI screening for prostate cancer.
Learn about Canon Medical's new CT scanner and why it is ideal for lung cancer screening.
Understand the evolution of AI in prostate MRI and its impact on clinical practice. How might AI help with prostate cancer screening by employing MRI as a supporting imaging modality?

  • Introduction - Prof. Stefan M. Niehues, (moderator), Berlin, Germany
  • Harnessing the Power of Automation in CT to Serve Screening Purposes - Dr. Russell Bull, Bournemouth, UK
  • AI in prostate MRI: current applications and perspectives (MRI)- Dr. Pierre Leyendecker, Strasbourg, France
  • Summary and perspective - Prof. Stefan M. Niehues, Berlin, Germany

* source:

Contact Us